Physician profile
Lacey A Olson
NPI 1548574015
$437.34
in general payments reported to CMS, 2019-2025
11 companies · $74.60 in 2025
The $74.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.35 · 2022: $66.43 · 2023: $121 · 2024: $137 · 2025: $74.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $129.24 | 2022-2025 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $93.66 | 2022-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $48.13 | 2023-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $43.87 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $24.68 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.04 | 2022 | |
| Organogenesis INC. | $15.57 | 2025 | Puraply Wound Matrix |
| Actelion Pharmaceuticals US, INC. | $15.04 | 2024 | Opsumit, Uptravi |
| Medtronic, INC. | $14.30 | 2023 | Minimed 780g |
| Pfizer INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.